Cambrex CEO and leadership

Mr. Loewald joined Cambrex in September 2020 and currently serves as Chief Executive Officer. Mr. Loewald is a 15-year veteran of Thermo Fisher Scientific, where he served in several senior executive roles during his tenure, including Chief Commercial Officer, President of the Analytical Instruments Group, President of the Laboratory Products Group, and President of the Laboratory Equipment and Environmental Instrument Divisions. Earlier in his career he held leadership positions at Tyco International and General Electric. Mr. Loewald currently serves on the Board of Directors of Harvard BioScience, a global developer, manufacturer and marketer of a broad range of solutions to advance life science.

Dorothy Donnelly-Brienza is a Senior Vice President and Chief Human Resources Officer at Cambrex.

Mr. Green joined Cambrex in January 2020 and currently serves as Executive Vice President and Chief Financial Officer. Mr. Green was previously with General Electric Corporation, where he began his career in 1990 and was most recently CFO of GE Power, a global business unit with $35 billion in revenue operating in 180 countries. In his tenure at GE, Robert served as CFO for eight global business units, including as CFO of GE Healthcare Bio-Sciences, a leading medical diagnostic and life sciences products company.

Mr. Steven M. Klosk is a President and Chief Executive Officer at Cambrex and is based in United States.

A results-oriented executive with over 20 years international experience successfully driving global change and operational improvement/integration within Fortune 1000 companies. Strong mix of strategic, operational and marketing skills derived from consulting (McKinsey & Co, Andersen Consulting, Price Waterhouse) and general management positions (ConvaTec(Bristol-Myers Squibb), IBM). Functional expertise in strategic planning, M&A, IT, finance, project management, supply chain, marketing, product commercialization and pricing and contracting.Career highlights include the:- Stabilization and turnaround of $700m Ostomy business through acquisitions and new products - Transfer of commercial operations in over 30 countries following a $4.2bn sale to private equity - Integration of $500m global business with 4000 employees - Implementation of SAP in over 30 countries within 15 months- Establishment of pan-European Shared Service Center supporting 30 countries

Mr. Loewald joined Cambrex in September 2020 and currently serves as Chief Executive Officer. Mr. Loewald is a 15-year veteran of Thermo Fisher Scientific, where he served in several senior executive roles during his tenure, including Chief Commercial Officer, President of the Analytical Instruments Group, President of the Laboratory Products Group, and President of the Laboratory Equipment and Environmental Instrument Divisions. Earlier in his career he held leadership positions at Tyco International and General Electric. Mr. Loewald currently serves on the Board of Directors of Harvard BioScience, a global developer, manufacturer and marketer of a broad range of solutions to advance life science.